| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/22/2008 | US7320976 Combination of brimonidine and timolol for topical ophthalmic use |
| 01/22/2008 | US7320968 Pharmaceutical composition |
| 01/22/2008 | US7320963 Methods and compositions for delivery of pharmaceutical agents |
| 01/22/2008 | US7320962 Hemoactive compositions and methods for their manufacture and use |
| 01/22/2008 | US7320870 Identifying a nucleic acid sequence encoding a lacritin receptor by contacting transfected cells with lacritin and detecting calcium signaling |
| 01/22/2008 | US7320867 Linker compound, ligand, and producing method thereof |
| 01/22/2008 | US7320859 Using nucleoprotein filament complexes to transfer nucleotide sequences into cells; nonviral gene therapy |
| 01/22/2008 | US7320800 Vaginally administrable progesterone-containing tablets and method for preparing same |
| 01/22/2008 | US7320793 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays |
| 01/22/2008 | US7320786 Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes |
| 01/22/2008 | CA2431515C Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition, and use thereof |
| 01/22/2008 | CA2427991C Cellulose particles for pharmaceuticals |
| 01/22/2008 | CA2382577C Injectable buprenorphine microparticle compositions and their use |
| 01/22/2008 | CA2382535C Mixed micellar pharmaceutical delivery system and method of preparation |
| 01/22/2008 | CA2368348C Biodegradable, injectable oligomer-polymer composition |
| 01/22/2008 | CA2347976C Plastics container containing stabilised drug formulations |
| 01/22/2008 | CA2338728C Pharmaceutical composition for injection based on paracetamol |
| 01/22/2008 | CA2316485C Sustained-release pharmaceutical composition |
| 01/22/2008 | CA2311308C Method for producing solid dosing forms |
| 01/22/2008 | CA2303807C Bioresorbable compositions for implantable prostheses |
| 01/22/2008 | CA2293589C Semisolid pharmaceutical formulation containing dexketoprofen trometamol |
| 01/22/2008 | CA2289914C Igf-1 receptor interacting proteins (iips), genes coding therefor and uses thereof |
| 01/22/2008 | CA2258849C Oxidized oligosaccharides |
| 01/22/2008 | CA2245708C Solid formulations containing trehalose |
| 01/22/2008 | CA2222676C New pharmaceutical composition with anaesthetic effect |
| 01/22/2008 | CA2215520C Chlamydia vaccines |
| 01/22/2008 | CA2178458C Stable complexes of crosslinked polyvinylpyrrolidone and iodine and method of making the same |
| 01/17/2008 | WO2008008944A1 Pharmaceutical suspensions comprising phenylephrine and method of preparation |
| 01/17/2008 | WO2008007932A1 Chitosan complex containing ph sensitive imidazole group and preparation method thereof |
| 01/17/2008 | WO2008007921A1 Paroxetine hydrochloride-containing sustained-release tablet having reduced dissolution variation |
| 01/17/2008 | WO2008007870A1 Apparatus for preparing particulate lecithin wax composition |
| 01/17/2008 | WO2008007868A1 Composition containing metal-acidic amino acid chelate accelerating absorption of metal |
| 01/17/2008 | WO2008007796A1 Controlled-release drug preparation and method for producing the same |
| 01/17/2008 | WO2008007554A1 Adhesive preparation |
| 01/17/2008 | WO2008007415A1 Inclusion coenzyme q10 and method of producing inclusion coenzyme q10 |
| 01/17/2008 | WO2008007383A1 Dried electrified hydrocolloid gels having unique structure and porosity |
| 01/17/2008 | WO2008006848A1 Composition comprising a retinoid and benzoyl peroxide |
| 01/17/2008 | WO2008006714A2 Improvements relating to biocidal compositions |
| 01/17/2008 | WO2008006658A1 Hydrogels containing low molecular weight alginates and biostructures made therefrom |
| 01/17/2008 | WO2008006544A2 Use of gelatin and a cross-linking agent for producing a cross-linking therapeutic composition |
| 01/17/2008 | WO2008006226A1 Transdermal formulations of synthetic cannabinoids and nano colloidal silica |
| 01/17/2008 | WO2008006187A2 Protein complexes for prevention and treatment of diseases with angiogenesis disorders |
| 01/17/2008 | WO2007133642A8 Sport drink containing amino acids and carbohydrates |
| 01/17/2008 | WO2007131017A3 A METHOD FOR DELIVERING A HUMAN CHORIONIC GONADOTROPIN (hCG) VACCINE FOR LONG-ACTING ANTIBODY PRODUCTION |
| 01/17/2008 | WO2007127354A3 Homogeneous dispersions containing citrus pulp and applications thereof |
| 01/17/2008 | WO2007113762A3 Bulking of soft tissue |
| 01/17/2008 | WO2007108031A3 An ophthalmic pharmaceutical composition containing amphiphilic polyaspartamide copolymers |
| 01/17/2008 | WO2007076371A3 Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
| 01/17/2008 | WO2007005838A3 Hcv inhibitors |
| 01/17/2008 | WO2005046571A3 Lactoferrin as an adjuvant in cancer vaccines |
| 01/17/2008 | WO2005021726A3 Immunogenic hiv compositions and related methods |
| 01/17/2008 | WO2002053187A3 Methods and transdermal compositions for pain relief |
| 01/17/2008 | US20080015343 Azithromycin dosage forms with reduced side effects |
| 01/17/2008 | US20080015332 Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 01/17/2008 | US20080015263 Compositions for delivery of therapeutics and other materials |
| 01/17/2008 | US20080015210 Base-Stabilized Polyorthoester Formulations |
| 01/17/2008 | US20080015155 Compositions and Methods for the Treatment of Inflammatory Conditions of the Mucosae, Skin and the Eye |
| 01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
| 01/17/2008 | US20080014321 Colouring Using Pearlescent Pigments in the Food and Pharmaceutical Sectors |
| 01/17/2008 | US20080014292 Composition for treating and/or preventing periodontal disease |
| 01/17/2008 | US20080014286 Metal-containing materials |
| 01/17/2008 | US20080014278 Metal-containing formulations and methods of use |
| 01/17/2008 | US20080014255 Liposome bonded with antibody and polyalkylene glycol |
| 01/17/2008 | US20080014254 Stable Crystal Modifications of Dotap Chloride |
| 01/17/2008 | US20080014253 Lipid-Based Drug Delivery Systems Containing Unnatural Phospholipase A2 Degradable Lipid Derivatives and the Therapeutic Uses Thereof |
| 01/17/2008 | US20080014249 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 01/17/2008 | US20080014246 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/17/2008 | US20080014237 Sustained release compositions, process for producing the same and use thereof |
| 01/17/2008 | US20080014233 Hybrid coated cosmetic powders and methods of making and using same |
| 01/17/2008 | US20080014210 Peptides and antibodies to muc 1 proteins |
| 01/17/2008 | US20080014174 Method for treating tumors, infectious diseases, and autoimmune diseases with an activated HLA matching donor-originating lymphocyte |
| 01/17/2008 | US20080014169 Compositions for Topical Enzymatic Debridement |
| 01/17/2008 | US20080014149 Methods and Compositions for Imaging and Biomedical Applications |
| 01/17/2008 | US20080011293 Stable Xylometazoline and Oxymetazoline Solution |
| 01/17/2008 | DE4215677B4 Pharmazeutisches Mittel The pharmaceutical agent |
| 01/17/2008 | CA2659382A1 Pharmaceutical suspensions comprising phenylephrine and method of preparation |
| 01/17/2008 | CA2657592A1 Adhesive patch containing fentanyl or a pharmaceutically acceptable salt thereof |
| 01/17/2008 | CA2657332A1 Transdermal formulations of synthetic cannabinoids and nano colloidal silica |
| 01/17/2008 | CA2656451A1 Composition comprising a retinoid and benzoyl peroxide |
| 01/17/2008 | CA2656229A1 Improvements relating to biocidal compositions |
| 01/16/2008 | EP1879013A1 Method for the design of self-emulsifying drug formulations |
| 01/16/2008 | EP1878766A1 Electrostatic bonding type polymer vesicle |
| 01/16/2008 | EP1878749A2 Individulized anti-cancer antibodies |
| 01/16/2008 | EP1878664A1 Process for producing metered dose inhaler formulations |
| 01/16/2008 | EP1878446A2 Formulation comprising buprenorphine |
| 01/16/2008 | EP1878445A1 A method, formulation and use thereor with improved oral absorption of drugs or nutrients |
| 01/16/2008 | EP1878444A1 Composition containing antidementia agent |
| 01/16/2008 | EP1878438A2 Ligand/llytic peptide compositions and methods of use |
| 01/16/2008 | EP1878437A2 Pharmacuetical formulations for sustained drug delivery |
| 01/16/2008 | EP1878435A1 Composition for inducing sleep containing vegetable essential oil component as the active component, transdermal absorption type sleep inducing agent containing the composition and method of producing the same |
| 01/16/2008 | EP1878429A1 Trenadermal absorption preparation |
| 01/16/2008 | EP1878426A1 Granular preparation containing biguanide compound |
| 01/16/2008 | EP1878425A1 Transdermal absorption accelerator |
| 01/16/2008 | EP1878424A2 Novel vaccine |
| 01/16/2008 | EP1878044A2 Xerogel films for the controlled release of pharmaceutically active molecules |
| 01/16/2008 | EP1877178A1 The use of a hydrophobic zeolite, that contains and gives a slow release of an active element, for treatment of skin |
| 01/16/2008 | EP1877103A2 Dendritic polymers with enhanced amplification and interior functionality |
| 01/16/2008 | EP1877102A2 Tab molecules |
| 01/16/2008 | EP1877101A2 Enzymes conjugated to antibodies via a peg heterobifuctional linker |
| 01/16/2008 | EP1877100A2 Liposomes |